Virax Biolabs VRAX Growth Metrics (2022-2026)

NASDAQ VRAX
$2.23 -0.08 (-3.65%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Virax Biolabs Quarterly Growth Metrics

Periods 8 quarters
Latest Mar 2026

Virax Biolabs reported asset growth of 29.53% for the quarter ended Mar 2026. These growth metrics cover 8 quarters of results from Mar 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Mar2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Growth Ratios
Assets Growth (1y) 22.93%20,046.22%32.58%-44.11%34.41%17.19%-39.48%29.53%
Assets Growth (3y) 417.28%409.10%2.55%-5.33%
Assets Growth (5y) 191.40%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 23.47%42,888.32%11.77%-61.62%42.64%17.82%-54.08%52.26%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 488.38%479.27%-9.88%-11.70%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) 225.50%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 14,202.53%107.96%36.65%20.90%-4.71%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) 471.06%
Total Debt Growth (1y) 0.00%3,791.70%-12.19%-12.29%
Total Debt Growth (3y) 105.19%-20.55%-42.04%
Total Debt Growth (5y) 49.94%

Virax Biolabs Growth Metrics API

Pull Virax Biolabs's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VRAX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY